Maze Therapeutics (MAZE) Retained Earnings (2024 - 2026)
Maze Therapeutics (MAZE) reported Retained Earnings of $855.5 million for Q1 2026, up 25.22% on a YoY basis from $683.2 million in Q1 2025, and up 274.76% sequentially from -$489.5 million in Q4 2025.
Maze Therapeutics (MAZE) Retained Earnings (2024 - 2026) Analysis & Trends
Maze Therapeutics (MAZE) has 3 years of Retained Earnings data on file, last reported at $855.5 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 25.22% year-over-year to $855.5 million; the trailing twelve-month figure through Mar 2026 stood at $855.5 million (up 25.22% YoY), and the FY2025 full-year result was -$489.5 million, down 36.58% from the prior year.
- Retained Earnings advanced to $855.5 million in Q1 2026, from -$489.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $855.5 million in Q1 2026 to a low of -$489.5 million in Q4 2025.
- A 3-year average of $153.8 million and a median of $162.4 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 36.58% in 2025 and increased 25.22% in 2026, its largest moves.
- Tracing MAZE's Retained Earnings over 3 years: stood at -$358.4 million in 2024, then slumped by 36.58% to -$489.5 million in 2025, then soared by 274.76% to $855.5 million in 2026.
- Business Quant data shows MAZE's Retained Earnings at $855.5 million in Q1 2026, -$489.5 million in Q4 2025, and -$455.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Maze Therapeutics | 1.49 Bn | 1.49 Bn | 18.21 Mn | 855.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 855.54 Mn |
| Dec 31, 2025 | -489.55 Mn |
| Sep 30, 2025 | -454.98 Mn |
| Jun 30, 2025 | 687.09 Mn |
| Mar 31, 2025 | 683.24 Mn |
| Dec 31, 2024 | -358.43 Mn |